Prolonged complete response with combined dabrafenib and trametinib after BRAF inhibitor failure in BRAF-mutant glioblastoma

Marina Kushnirsky; Lynn G. Feun; Sakir H. Gultekin; MacArena I. De La Fuente

doi:10.1200/PO.19.00272

Prolonged complete response with combined dabrafenib and trametinib after BRAF inhibitor failure in BRAF-mutant glioblastoma

Marina Kushnirsky, Lynn G. Feun, Sakir H. Gultekin, MacArena I. De La Fuente

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	44-50
Number of pages	7
Journal	JCO Precision Oncology
Volume	4
DOIs	https://doi.org/10.1200/PO.19.00272
State	Published - 2020

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1200/PO.19.00272

Cite this

@article{3391a4a79db04020931689ee4d4bfaca,

title = "Prolonged complete response with combined dabrafenib and trametinib after BRAF inhibitor failure in BRAF-mutant glioblastoma",

author = "Marina Kushnirsky and Feun, {Lynn G.} and Gultekin, {Sakir H.} and {De La Fuente}, {MacArena I.}",

note = "Funding Information: Supported by grants from the American Cancer Society (M.I.d.l.F.) and the Sylvester Comprehensive Cancer Center (M.I.d.l.F.).",

year = "2020",

doi = "10.1200/PO.19.00272",

language = "English (US)",

volume = "4",

pages = "44--50",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Prolonged complete response with combined dabrafenib and trametinib after BRAF inhibitor failure in BRAF-mutant glioblastoma

AU - Kushnirsky, Marina

AU - Feun, Lynn G.

AU - Gultekin, Sakir H.

AU - De La Fuente, MacArena I.

N1 - Funding Information: Supported by grants from the American Cancer Society (M.I.d.l.F.) and the Sylvester Comprehensive Cancer Center (M.I.d.l.F.).

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85091514814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091514814&partnerID=8YFLogxK

U2 - 10.1200/PO.19.00272

DO - 10.1200/PO.19.00272

M3 - Article

AN - SCOPUS:85091514814

VL - 4

SP - 44

EP - 50

JO - JCO Precision Oncology

JF - JCO Precision Oncology

SN - 2473-4284

ER -

Prolonged complete response with combined dabrafenib and trametinib after BRAF inhibitor failure in BRAF-mutant glioblastoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this